CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats

Abstract Background Obstructive sleep apnoea (OSA) induced chronic kidney disease is mainly caused by chronic intermittent hypoxia (CIH). Our study investigate the mechanism underlying CIH-induced renal damage and whether the cannabinoid receptor 1 (CB1R) antagonist rimonabant (Ri) alleviates CIH-in...

Full description

Bibliographic Details
Main Authors: Li Zhao, Tao Liu, Zhan-jun Dou, Mei-ting Wang, Zi-xuan Hu, Bei Wang
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-021-02362-6
id doaj-39ce715f58944335af44af1b618196f1
record_format Article
spelling doaj-39ce715f58944335af44af1b618196f12021-05-02T11:46:31ZengBMCBMC Nephrology1471-23692021-04-0122111210.1186/s12882-021-02362-6CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in ratsLi Zhao0Tao Liu1Zhan-jun Dou2Mei-ting Wang3Zi-xuan Hu4Bei Wang5Shanxi Medical UniversityShanxi Medical UniversityShanxi Medical UniversityShanxi Medical UniversityShanxi Medical UniversityThe Second Hospital of Shanxi Medical UniversityAbstract Background Obstructive sleep apnoea (OSA) induced chronic kidney disease is mainly caused by chronic intermittent hypoxia (CIH). Our study investigate the mechanism underlying CIH-induced renal damage and whether the cannabinoid receptor 1 (CB1R) antagonist rimonabant (Ri) alleviates CIH-induced renal injury. Methods Male Sprague-Dawley rats were randomly divided into five groups: one normal control (NC) group, two chronic intermittent hypoxia (CIH) groups, and two CIH + Ri groups. Rats in the NC groups were exposed to room air, while the CIH groups were exposed to a CIH environment for 4 weeks (4w CIH group) and 6 weeks (6w CIH group), respectively. Additionally, rats in the CIH + Ri groups were administered 1.5 mg/kg/day Ri for 4 weeks (4w CIH + Ri group) and 6 weeks (6w CIH + Ri group), respectively. Following this, the rats were euthanized and kidneys were excised for downstream analysis. In the renal tissues, the morphological alterations were examined via haematoxylin eosin (HE) staining and periodic acid schiff (PAS) staining, CB1R, Fis1, Mfn1, and p66Shc expression was assessed through western blot and immunohistochemistry, and the mitochondrial ultrastructural changes in kidney sections were assessed by electron microscopy. Results CB1R expression in the 4w and 6w CIH groups was significantly elevated, and further increased with prolonged hypoxia; however, Ri prevented the increase in CIH-induced CB1R expression. Fis1 and p66Shc expression in the CIH groups were increased, but Mfn1 expression decreased. Ri decreased Fis1 and p66Shc expression and increased Mfn1 expression. Renal damage in the 4w or 6w CIH + Ri group was evidently improved compared with that in the 4w or 6w CIH group. CB1R expression was positively correlated with Fis1 and p66Shc and negatively correlated with Mfn1. Meanwhile, electron microscopy showed that the percentage of fragmented mitochondria in the tubular cells in each group was consistent with the trend of CB1R expression. Conclusion CIH causes endocannabinoid disorders and induces abnormal mitochondrial dynamics, resulting in renal injury. Treatment with CB1R antagonists reduces CIH-induced renal damage by inhibiting dysregulated renal mitochondrial dynamics.https://doi.org/10.1186/s12882-021-02362-6Obstructive sleep apnoeaChronic intermittent hypoxiaCannabinoid receptor system 1;renal injury; mitochondrial dynamicsRimonabant
collection DOAJ
language English
format Article
sources DOAJ
author Li Zhao
Tao Liu
Zhan-jun Dou
Mei-ting Wang
Zi-xuan Hu
Bei Wang
spellingShingle Li Zhao
Tao Liu
Zhan-jun Dou
Mei-ting Wang
Zi-xuan Hu
Bei Wang
CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
BMC Nephrology
Obstructive sleep apnoea
Chronic intermittent hypoxia
Cannabinoid receptor system 1;renal injury; mitochondrial dynamics
Rimonabant
author_facet Li Zhao
Tao Liu
Zhan-jun Dou
Mei-ting Wang
Zi-xuan Hu
Bei Wang
author_sort Li Zhao
title CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
title_short CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
title_full CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
title_fullStr CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
title_full_unstemmed CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
title_sort cb1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
publisher BMC
series BMC Nephrology
issn 1471-2369
publishDate 2021-04-01
description Abstract Background Obstructive sleep apnoea (OSA) induced chronic kidney disease is mainly caused by chronic intermittent hypoxia (CIH). Our study investigate the mechanism underlying CIH-induced renal damage and whether the cannabinoid receptor 1 (CB1R) antagonist rimonabant (Ri) alleviates CIH-induced renal injury. Methods Male Sprague-Dawley rats were randomly divided into five groups: one normal control (NC) group, two chronic intermittent hypoxia (CIH) groups, and two CIH + Ri groups. Rats in the NC groups were exposed to room air, while the CIH groups were exposed to a CIH environment for 4 weeks (4w CIH group) and 6 weeks (6w CIH group), respectively. Additionally, rats in the CIH + Ri groups were administered 1.5 mg/kg/day Ri for 4 weeks (4w CIH + Ri group) and 6 weeks (6w CIH + Ri group), respectively. Following this, the rats were euthanized and kidneys were excised for downstream analysis. In the renal tissues, the morphological alterations were examined via haematoxylin eosin (HE) staining and periodic acid schiff (PAS) staining, CB1R, Fis1, Mfn1, and p66Shc expression was assessed through western blot and immunohistochemistry, and the mitochondrial ultrastructural changes in kidney sections were assessed by electron microscopy. Results CB1R expression in the 4w and 6w CIH groups was significantly elevated, and further increased with prolonged hypoxia; however, Ri prevented the increase in CIH-induced CB1R expression. Fis1 and p66Shc expression in the CIH groups were increased, but Mfn1 expression decreased. Ri decreased Fis1 and p66Shc expression and increased Mfn1 expression. Renal damage in the 4w or 6w CIH + Ri group was evidently improved compared with that in the 4w or 6w CIH group. CB1R expression was positively correlated with Fis1 and p66Shc and negatively correlated with Mfn1. Meanwhile, electron microscopy showed that the percentage of fragmented mitochondria in the tubular cells in each group was consistent with the trend of CB1R expression. Conclusion CIH causes endocannabinoid disorders and induces abnormal mitochondrial dynamics, resulting in renal injury. Treatment with CB1R antagonists reduces CIH-induced renal damage by inhibiting dysregulated renal mitochondrial dynamics.
topic Obstructive sleep apnoea
Chronic intermittent hypoxia
Cannabinoid receptor system 1;renal injury; mitochondrial dynamics
Rimonabant
url https://doi.org/10.1186/s12882-021-02362-6
work_keys_str_mv AT lizhao cb1receptorantagonistrimonabantprotectsagainstchronicintermittenthypoxiainducedrenalinjuryinrats
AT taoliu cb1receptorantagonistrimonabantprotectsagainstchronicintermittenthypoxiainducedrenalinjuryinrats
AT zhanjundou cb1receptorantagonistrimonabantprotectsagainstchronicintermittenthypoxiainducedrenalinjuryinrats
AT meitingwang cb1receptorantagonistrimonabantprotectsagainstchronicintermittenthypoxiainducedrenalinjuryinrats
AT zixuanhu cb1receptorantagonistrimonabantprotectsagainstchronicintermittenthypoxiainducedrenalinjuryinrats
AT beiwang cb1receptorantagonistrimonabantprotectsagainstchronicintermittenthypoxiainducedrenalinjuryinrats
_version_ 1721491715819307008